The Pharmacologic Basis for the Treatment of Developmental and Acute Laminitis

Veterinary Clinics of North America - Equine Practice

Volumn 26, Issue 1, 2010, Pages 115-124

  Belknap, James K ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Digital blood flow; Inflammation; Laminitis; Nonsteroidal antiinflammatory drugs; Treatment

Indexed keywords

ANTICOAGULANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; VASODILATOR AGENT;

ACUTE DISEASE; ANIMAL; ANIMAL DISEASE; FOOT DISEASE; HOOF AND CLAW; HORSE; HORSE DISEASE; INFLAMMATION; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW; VASCULARIZATION;

ACUTE DISEASE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICOAGULANTS; FOOT DISEASES; HOOF AND CLAW; HORSE DISEASES; HORSES; INFLAMMATION; VASODILATOR AGENTS;

EID: 77950346788     PISSN: 07490739     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cveq.2010.01.003     Document Type: Review

References (61)

1. Loftus J.P., Black S.J., Pettigrew A., et al. Early laminar events involving endothelial activation in horses with black walnut-induced laminitis. Am J Vet Res 68 (2007) 1205-1211
2. Belknap J.K., Moore J.N., and Crouser E.C. Sepsis-From human organ failure to laminar failure. Vet Immunol Immunopathol 129 (2009) 155-157
3. Geor R.J., and Harris P. Dietary management of obesity and insulin resistance: countering risk for laminitis. Vet Clin North Am Equine Pract 25 (2009) 51-65 vi
4. Baxter G.M., and Morrison S. Complications of unilateral weight bearing. Vet Clin North Am Equine Pract 24 (2008) 621-642 ix
5. Belknap J.K., Giguere S., Pettigrew A., et al. Lamellar pro-inflammatory cytokine expression patterns in laminitis at the developmental stage and at the onset of lameness: innate vs. adaptive immune response. Equine Vet J 39 (2007) 42-47
6. Hurley D.J., Parks R.J., Reber A.J., et al. Dynamic changes in circulating leukocytes during the induction of equine laminitis with black walnut extract. Vet Immunol Immunopathol 110 (2006) 195-206
7. Garner H.E., Coffman J.R., Hahn A.W., et al. Equine laminitis of alimentary origin: an experimental model. Am J Vet Res 36 (1975) 441-444
8. van Eps A.W., and Pollitt C.C. Equine laminitis induced with oligofructose. Equine Vet J 38 (2006) 203-208
9. Hudson N.P.H., McClintock S.A., and Hodgson D.R. Case of pleuropneumonia with complications in a Thoroughbred Stallion. Equine Vet Educ 11 (1999) 286-289
10. Parsons C.S., Orsini J.A., Krafty R., et al. Risk factors for development of acute laminitis in horses during hospitalization: 73 cases (1997-2004). J Am Vet Med Assoc 230 (2007) 885-889
11. Mulville P. Equine monocytic ehrlichiosis (Potomac horse fever): a review. Equine Vet J 23 (1991) 400-404
12. Sprouse R.F., Garner H.E., and Green E.M. Plasma endotoxin levels in horses subjected to carbohydrate induced laminitis. Equine Vet J 19 (1987) 25-28
13. Bailey S.R., Adair H.S., Reinemeyer C.R., et al. Plasma concentrations of endotoxin and platelet activation in the developmental stage of oligofructose-induced laminitis. Vet Immunol Immunopathol 129 (2009) 167-173
14. Liaudet L., Szabo C., Evgenov O.V., et al. Flagellin from gram-negative bacteria is a potent mediator of acute pulmonary inflammation in sepsis. Shock 19 (2003) 131-137
15. Buras J.A., Holzmann B., and Sitkovsky M. Animal models of sepsis: setting the stage. Nat Rev Drug Discov 4 (2005) 854-865
16. Southwood L.L. Postoperative management of the large colon volvulus patient. Vet Clin North Am Equine Pract 20 (2004) 167-197
17. Durando M.M., MacKay R.J., Linda S., et al. Effects of polymyxin B and Salmonella typhimurium antiserum on horses given endotoxin intravenously. Am J Vet Res 55 (1994) 921-927
18. Garner H.E., Sprouse R.F., and Lager K. Cross protection of ponies from sublethal Escherichia coli endotoxemia by Salmonella typhimurium antiserum. Equine Pract 10 (1988) 10-17
19. Morris D.D., Whitlock R.H., and Corbeil L.B. Endotoxemia in horses: protection provided by antiserum to core lipopolysaccharide. Am J Vet Res 47 (1986) 544-550
20. Pollitt C.C., and Davies C.T. Equine laminitis: its development coincides with increased sublamellar blood flow. Equine Vet J Suppl 26 (1998) 125-132
21. Eaton S.A., Allen D.A., Eades S.C., et al. Digital Starling forces and hemodynamics during early laminitis induced by an aqueous extract of black walnut (Juglans nigra) in horses. Vet Surg 23 (1994) 400-401
22. Allen Jr. D., Clark E.S., Moore J.N., et al. Evaluation of equine digital Starling forces and hemodynamics during early laminitis. Am J Vet Res 51 (1990) 1930-1934
23. Adair III H.S., Goble D.O., Schmidhammer J.L., et al. Laminar microvascular flow, measured by means of laser Doppler flowmetry, during the prodromal stages of black walnut-induced laminitis in horses. Am J Vet Res 61 (2000) 862-868
24. Hood D.M., Wagner I.P., and Brumbaugh G.W. Evaluation of hoof wall surface temperature as an index of digital vascular perfusion during the prodromal and acute phases of carbohydrate-induced laminitis in horses. Am J Vet Res 62 (2001) 1167-1172
25. Noschka E., Moore J.N., Peroni J.F., et al. Thromboxane and isoprostanes as inflammatory and vasoactive mediators in black walnut heartwood extract induced equine laminitis. Vet Immunol Immunopathol 129 (2009) 200-210
26. Peroni J.F., Moore J.N., Noschka E., et al. Predisposition for venoconstriction in the equine laminar dermis: implications in equine laminitis. J Appl Phys 100 (2006) 759-763
27. Ingle-Fehr J.E., and Baxter G.M. Evaluation of digital and laminar blood flow in horses given a low dose of endotoxin. Am J Vet Res 59 (1998) 192-196
28. Hunt R.J., Allen D., and Moore J.N. Effect of endotoxin administration on equine digital hemodynamics and starling forces. Am J Vet Res 51 (1990) 1703-1707
29. Robertson T.P., Bailey S.R., and Peroni J.F. Equine laminitis: a journey to the dark side of venous. Vet Immunol Immunopathol 129 (2009) 164-166
30. Ingle-Fehr J.E., and Baxter G.M. The effect of oral isoxsuprine and pentoxifylline on digital and laminar blood flow in healthy horses. Vet Surg 28 (1999) 154-160
31. Hunt R.J., Brandon C.I., and McCann M.E. Effects of acetylpromazine, xylazine, and vertical load on digital arterial blood-flow in horses. Am J Vet Res 55 (1994) 375-378
32. Leise B.S., Fugler L.A., Stokes A.M., et al. Effects of intramuscular administration of acepromazine on palmar digital blood flow, palmar digital arterial pressure, transverse facial arterial pressure, and packed cell volume in clinically healthy, conscious horses. Vet Surg 36 (2007) 717-723
33. Hinckley K.A., Fearn S., Howard B.R., et al. Nitric oxide donors as treatment for grass induced acute laminitis in ponies. Equine Vet J 28 (1996) 17-28
34. Gilhooly M.H., Eades S.C., Stokes A.M., et al. Effects of topical nitroglycerine patches and ointment on digital venous plasma nitric oxide concentrations and digital blood flow in healthy conscious horses. Vet Surg 34 (2005) 604-609
35. Krotz F., Schiele T.M., Klauss V., et al. Selective COX-2 inhibitors and risk of myocardial infarction. J Vasc Res 42 (2005) 312-324
36. Sanghi S., MacLaughlin E.J., Jewell C.W., et al. Cyclooxygenase-2 inhibitors: a painful lesson. Cardiovasc Hematol Disord Drug Targets 6 (2006) 85-100
37. Eades S.C., Stokes A.M., Johnson P.J., et al. Serial alterations in digital hemodynamics and endothelin-1 immunoreactivity, platelet-neutrophil aggregation, and concentrations of nitric oxide, insulin, and glucose in blood obtained from horses following carbohydrate overload. Am J Vet Res 68 (2007) 87-94
38. Weiss D.J., Evanson O.A., McClenahan D., et al. Evaluation of platelet activation and platelet-neutrophil aggregates in ponies with alimentary laminitis. Am J Vet Res 58 (1997) 1376-1380
39. Belknap J.K., and Moore J.N. Evaluation of heparin for prophylaxis of equine laminitis: 71 cases (1980-1986). J Am Vet Med Assoc 195 (1989) 505-507
40. Cohen N.D., Parson E.M., Seahorn T.L., et al. Prevalence and factors associated with development of laminitis in horses with duodenitis/proximal jejunitis: 33 cases (1985-1991). J Am Vet Med Assoc 204 (1994) 250-254
41. Mahaffey E.A., and Moore J.N. Erythrocyte agglutination associated with heparin treatment in three horses. J Am Vet Med Assoc 189 (1986) 1478-1480
42. de la Rebiere de Pouyade G., Grulke S., Detilleux J., et al. Evaluation of low-molecular-weight heparin for the prevention of equine laminitis after colic surgery. J Vet Emerg Crit Care (San Antonio) 19 (2009) 113-119
43. Pollitt C.C. Basement membrane pathology: a feature of acute equine laminitis. Equine Vet J 28 (1996) 38-46
44. Pollitt C.C., and Daradka M. Equine laminitis basement membrane pathology: loss of type IV collagen, type VII collagen and laminin immunostaining. Equine Vet J Suppl 26 (1998) 139-144
45. Pollitt C.C., Pass M.A., and Pollitt S. Batimastat (BB-94) inhibits matrix metalloproteinases of equine laminitis. Equine Vet J Suppl 26 (1998) 119-124
46. Loftus J.P., Belknap J.K., and Black S.J. Matrix metalloproteinase-9 in laminae of black walnut extract treated horses correlates with neutrophil abundance. Vet Immunol Immunopathol 113 (2006) 267-276
47. Mungall B.A., and Pollitt C.C. Zymographic analysis of equine laminitis. Histochem Cell Biol 112 (1999) 467-472
48. Loftus J.P., Johnson P.J., Belknap J.K., et al. Leukocyte-derived and endogenous matrix metalloproteinases in the lamellae of horses with naturally acquired and experimentally induced laminitis. Vet Immunol Immunopathol 129 (2009) 221-230
49. French K.R., and Pollitt C.C. Equine laminitis: loss of hemidesmosomes in hoof secondary epidermal lamellae correlates to dose in an oligofructose induction model: an ultrastructural study. Equine Vet J 36 (2004) 230-235
50. Nourian A.R., Baldwin G.I., van Eps A.W., et al. Equine laminitis: ultrastructural lesions detected 24-30 hours after induction with oligofructose. Equine Vet J 39 (2007) 360-364
51. Noschka E., Vandenplas M.L., Hurley D.J., et al. Temporal aspects of laminar gene expression during the developmental stages of equine laminitis. Vet Immunol Immunopathol 129 (2009) 242-253
52. Eckert R.E., Sharief Y., and Jones S.L. p38 mitogen-activated kinase (MAPK) is essential for equine neutrophil migration. Vet Immunol Immunopathol 129 (2009) 181-191
53. Tannhof E., Yin C., Pettigrew A., et al. Laminar regulation of STAT1 and STAT3 at developmental stages and at the onset of lameness in the black walnut extract model of laminitis. J Vet Intern Med 21 (2007) 662
54. Yin C., Pettigrew A., Loftus J.P., et al. Tissue concentrations of 4-HNE in the black walnut extract model of laminitis: indication of oxidant stress in affected laminae. Vet Immunol Immunopathol 129 (2009) 211-215
55. Housby J.N., Cahill C.M., Chu B., et al. Non-steroidal anti-inflammatory drugs inhibit the expression of cytokines and induce HSP70 in human monocytes. Cytokines 11 (1999) 347-358
56. Sagi S.A., Weggen S., Eriksen J., et al. The non-cyclooxygenase targets of non-steroidal anti-inflammatory drugs, lipoxygenases, peroxisome proliferator-activated receptor, inhibitor of kappa B kinase, and NF kappa B, do not reduce amyloid beta 42 production. J Biol Chem 278 (2003) 31825-31830
57. Semrad S.D., Hardee G.E., Hardee M.M., et al. Low dose flunixin meglumine: effects on eicosanoid production and clinical signs induced by experimental endotoxaemia in horses. Equine Vet J 19 (1987) 201-206
58. MacAllister C.G., Morgan S.J., Borne A.T., et al. Comparison of adverse effects of phenylbutazone, flunixin meglumine, and ketoprofen in horses. J Am Vet Med Assoc 202 (1993) 71-77
59. Williams J.M., Ravis W., Loftus J., et al. Effect of intravenous lidocaine administration on leukocyte emigration in the black walnut extract model of laminitis. J Vet Intern Med 23 (2009) 781
60. Dua P., and Gude R.P. Antiproliferative and antiproteolytic activity of pentoxifylline in cultures of B16F10 melanoma cells. Cancer Chemother Pharmacol 58 (2006) 195-202
61. Nourian A.R., Mills P.C., and Pollitt C.C. Development of intraosseous infusion of the distal phalanx to access the foot lamellar circulation in the standing, conscious horse. Vet J 183 3 (2010) 273-277